Nivolumab and Alcohol / Food Interactions
There is 1 alcohol/food/lifestyle interaction with nivolumab:
High Blood Pressure (Hypertension)
Major Potential Hazard, Moderate plausibility
monoclonal antibodies - infusion reactions
The use of monoclonal antibodies administered via IV infusion may cause serious infusion reactions, including bronchospasm, hypoxia, dyspnea, fluctuations in blood pressure, laryngeal edema and pulmonary edema. Caution should be taken in patients with a history of cardiopulmonary disease as they may require additional post-infusion medications to manage respiratory complications. It is recommended to administer required intravenous hydration and premedication with antihistamines, analgesics, and antipyretics before administration. Monitor closely for signs and symptoms of infusion reactions during and for at least 4 hours following completion of each infusion in a setting where cardiopulmonary resuscitation medication and equipment are available. Immediately interrupt or permanently discontinue treatment and institute supportive management for severe or prolonged infusion reactions as appropriate.
Nivolumab drug interactions
There are 4 drug interactions with nivolumab
Nivolumab disease interactions
There are 11 disease interactions with nivolumab which include:
- infections
- infusion reactions
- tumor lysis syndrome
- colitis
- diabetes
- hepatic impairment
- neurologic disorders
- pneumonitis
- renal dysfunction
- thyroid disease
- myasthenia gravis
More about nivolumab
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- En Español
- 68 Reviews
- Drug class: anti-PD-1 monoclonal antibodies
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
